Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
849 items

Lab-grown ‘mini-corneas’ mimic developing human corneas

Three-dimensional, lab-grown “mini-corneas” resemble the developing human cornea, making them a powerful new tool for the study of corneal diseases, a study finds.

Patients with specific types of lipids may be at higher risk of developing blinding eye disease

Scientists find association between lipid metabolism and glaucoma.
Retinal OCT showing fluid pocket in the macula

Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).

Training, ocular imaging standards top priorities among global ophthalmology leaders

Representatives from a dozen global organizations and as many countries launched a new collaboration with the National Eye Institute aimed at advancing vision research and eye heath globally

New nerve insights could someday help heal certain types of blindness and paralysis

UConn School of Medicine researchers report that a small population of nerve cells exist in everyone that could be coaxed to regrow, potentially restoring sight and movement after injury.
Thounaojam with retinal images in background.

Bile acid receptor could be innovative target in protecting the vision of premature newborns

Medical College of Georgia scientists have early evidence that targeting the bile acid receptor could provide earlier, more impactful treatments for premature babies to prevent retinopathy of prematurity.
Artistic rendering of retinal blood vessels with blood vessel damage.

Experimental drug inhibits or prevents diabetic eye disease in Wilmer Eye Institute study

Researchers from Johns Hopkins Medicine show that experimental drug may prevent or slow vision loss in people with diabetic retinopathy, a complication of diabetes.
capsules

Multivitamin improves memory in older adults, study finds

Taking a daily multivitamin supplement can slow age-related memory decline, finds a large study led by researchers at Columbia University and Brigham and Women’s Hospital/Harvard.
EyeDrops_GlaucomaMedicines.

AI used to advance drug delivery system for glaucoma and other chronic diseases

Researchers have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

NEI explores potential impacts of climate change on eye health

To better understand eye health care needs of the future, the National Eye Institute convened a panel of experts April 26, 2023, at the annual meeting of the Association for Research in Vision and Ophthalmology.